Search
for
Sort by
Research 181–210 of 1000+
- Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies
- Alopecia: managing the basics
- Alopecia and hirsutism*
- Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
- A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- CLINICAL UPDATES IN HAIR
- Analysis of Female Pattern Hair loss
- Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- The Role of Sex Hormones in Skin Health
- HAIR REGROWTH
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Acne keloidalis nuchae: prevalence, impact, and management challenges
- Nonclassic adrenal hyperplasia
- Acquired scalp alopecia. Part II: A review
- Endocrine evaluation of hirsutism
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Endocrine evaluation of hirsutism
- Anti-Alopecia Activity of Coumarin Derivatives Isolated from Merremia peltata Leaves and Computational Study of Their Binding to Androgen Receptors Using Molecular Docking and Molecular Dynamic Simulation
- Assessment of the efficacy of topical antiandrogen; spironolactone in patients with androgenetic alopecia by dermoscopy
- Cosmetic Approach for Men
- Exclusive androgenic effect of dehydroepiandrosterone in sebaceous glands of rat skin
- Stem cells and alopecia: a review of pathogenesis
- Alopecia Areata
- Lichen planopilaris in men: a retrospective clinicopathologic study of 19 patients
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Androgen effects on the skin
- Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics
- 9 Pilosebaceous physiology in relation to hirsutism and acne